APOBEC2 and cancer: We postulate that reduced expression of APOBEC2 may prevent or reduce C-to-U editing, as described for APOBEC3 for human papillomavirus, thereby minimizing hypermutations into the CRPV genome and facilitating cancer progression [56,57].